The Fundació Puigvert has successfully performed the first two surgeries in Spain with a new state-of-the-art surgical robot, one of the most advanced in the world with this healthcare technology
A moment of the intervention of the HUGO surgical robot at the Fundació Puigvert/Courtesy photo
With this double surgery, performed on patients with prostate cancer and kidney cancer, this Foundation has become the second hospital in Europe to perform an operation with this system, and one of the first in the world, this health center has reported.
The new surgical robot, called HUGO and developed by Medtronic, introduces an open console, portability, artificial intelligence and a modular design for the first time in a system of its kind, while improving precision and ergonomics.
This robot guarantees patients the advantages of minimally invasive surgery, with fewer complications and less recovery time after the intervention, according to its creators.
Dr. Joan Palou, director of the Urology Service of the Fundació Puigvert, highlights the “solvency and functionality” of the new robot.
The urologist affirms that, although the new tool will allow all types of intervention, it stands out in “some surgeries in which scientific evidence shows that the advantages are unquestionable, such as radical prostatectomy for prostate cancer or partial nephrectomy for kidney cancer, first two operations that we have carried out successfully”.
The technology of this robot has a mobile system that allows it to be moved easily inside and outside the operating room.
In a complementary way, it incorporates artificial intelligence to record the interventions and make a selection of the key moments of the surgery automatically.
Currently, robotic surgery is used in only 3 percent of procedures in the world.
Dr. Alberto Breda, head of the Urology Oncology Unit and the Renal Transplant Surgical Team, stresses: “Surgeons want to operate with robotic surgery because it has been shown to be the best way, and it offers clear advantages for patients, such as decrease in bleeding, postoperative pain and days of hospitalization».
“The ideal scenario, and the one posed by the arrival of HUGO and the rest that will arrive, is that it will stop being done only in selected cases, like now, to be done routinely,” adds Dr. Breda, president of the robotic surgery section of the European Society of Urology.
Despite advances in medical technology over the past decade, cost and availability barriers have put robotic-assisted surgery out of reach for many hospitals and, consequently, patients, notes the Puigvert Foundation.
0 Comments:
Publicar un comentario